Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Puma Biotechnology Inc, 3 years.
Puma Biotechnology Inc
Director
Rigel Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Puma Biotechnology Inc June 11, 202698.2%
-
Puma Biotechnology Inc June 11, 202598.4%
-
Puma Biotechnology Inc June 18, 202497.7%
-
Puma Biotechnology Inc June 13, 202397.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| May 15, 2026 | Rigel Pharmaceuticals Inc. | Grant or award | +5,750 | — | — |
| Nov 11, 2025 | Puma Biotechnology Inc | Open-market sale | −20,000 | $4.86 | $97,200 |
| Jun 11, 2025 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Aug 12, 2024 | Puma Biotechnology Inc | Open-market sale | −23,358 | $3.49 | $81,519 |
| Jun 18, 2024 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Nov 7, 2023 | Puma Biotechnology Inc | Open-market sale | −25,000 | $2.83 | $70,750 |
| Jun 13, 2023 | Puma Biotechnology Inc | Open-market sale | −13,500 | $3.45 | $46,575 |
| Jun 13, 2023 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.